Amicus Therapeutics (FOLD) 8.88 $FOLD
Amicus provides 2015 outlook
Seeking Alpha - at Seeking Alpha - 2 hrs 38 mins ago
FOLD: 8.88 (+0.04)
Amicus Therapeutics Provides Full-Year 2015 Strategic Outlook and Financial Guidance
GlobeNewswire - Mon Jan 12, 6:30AM CST
MAA Submission for Migalastat Monotherapy for Fabry Disease on Track for Mid-2015
FOLD: 8.88 (+0.04)
Amicus Therapeutics (FOLD) Weak On High Volume
at The Street - Fri Jan 09, 9:03AM CST
Trade-Ideas LLC identified Amicus Therapeutics (FOLD) as a weak on high relative volume candidate
FOLD: 8.88 (+0.04)
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1
at The Street - Thu Jan 08, 12:09PM CST
The much ballyhooed J.P. Morgan Healthcare Conference kicks off Monday in San Francisco. Here are capsule summaries of some of the expected story lines from presenting companies.
OREX: 5.75 (-0.03), BIIB: 347.84 (+5.50), VRTX: 118.31 (-3.90), ESRX: 83.08 (-1.82), ACAD: 34.25 (+0.88), PCYC: 123.71 (-0.49), GILD: 101.21 (-1.00), NPSP: 45.35 (+3.44), SNY: 44.92 (+0.37), FOLD: 8.88 (+0.04), CELG: 117.00 (+3.33)
Migalstat HCL has positive impact on cardiac endpoint in Fabry study
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 10:31AM CST
FOLD: 8.88 (+0.04)
41.4% Return Seen to Date on SmarTrend Amicus Therapeutics Call (FOLD)
Comtex SmarTrend(R) - Thu Jan 08, 9:09AM CST
SmarTrend identified an Uptrend for Amicus Therapeutics (NASDAQ:FOLD) on November 17th, 2014 at $6.66. In approximately 2 months, Amicus Therapeutics has returned 41.44% as of today's recent price of $9.42.
FOLD: 8.88 (+0.04)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 8:15AM CST
NRX: 7.90 (-1.19), BIND: 6.76 (-0.45), NBG: 1.66 (+0.09), MBT: 7.95 (-0.16), STML: 16.33 (+0.52), BIOD: 1.55 (-0.03), SIG: 124.42 (-0.50), PBR: 6.57 (-0.49), NBIX: 29.51 (+1.22), PIR: 16.75 (-0.01), VLCCF: 5.08 (+0.49), CONN: 18.28 (+0.22), CYTR: 3.44 (-0.14), PLX: 2.34 (+0.05), MEET: 1.43 (+0.01), INFI: 15.15 (+0.38), CYRN: 2.09 (+0.07), APOL: 26.05 (-0.89), CJJD: 3.16 (+0.39), CRK: 5.15 (-0.51), FOLD: 8.88 (+0.04), GST: 2.21 (-0.17)
Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac Endpoints From Fabry Monotherapy Study 011 and Long Term Extension Study
GlobeNewswire - Thu Jan 08, 6:41AM CST
Statistically Significant Improvements in Key Cardiac Parameter in Fabry Patients Previously Naïve to Therapy
FOLD: 8.88 (+0.04)
Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains
at The Street - Tue Jan 06, 7:25PM CST
The markets are presenting a buying opportunity at current levels, but only if you know which stocks to buy, Cramer says.
TSLA: 202.21 (-4.45), GE: 23.98 (-0.05), OVAS: 49.24 (-0.92), NMM: 12.41 (+0.12), XOM: 90.33 (-1.77), T: 33.49 (+0.09), ESPR: 48.52 (+3.58), IBM: 156.44 (-2.67), IRE: 14.01 (-0.12), DTV: 84.72 (-0.66), PTCT: 53.70 (+0.08), RCPT: 120.88 (-3.63), TEG: 77.50 (-0.53), PPG: 226.25 (-0.72), WAG: 76.05 (-0.49), BLUE: 101.95 (-1.68), TGTX: 15.98 (-0.88), WFC: 52.05 (-0.63), BA: 130.87 (-0.67), RAD: 7.79 (-0.04), ISIS: 73.34 (+1.08), RNA: 18.77 (+0.01), ACHN: 14.64 (+0.08), JCP: 8.14 (+0.23), CVS: 97.20 (-0.72), MCD: 93.01 (-0.20), AGIO: 131.55 (+3.43), CVX: 105.88 (-2.33), VZ: 47.08 (+0.32), FOLD: 8.88 (+0.04)
3 Biotech Stocks We're Watching Closest Ahead of the JPMorgan Healthcare Conference
Motley Fool Staff - Motley Fool - Mon Jan 05, 6:52AM CST
Source: GlaxoSmithKline via Flickr. When it comes to healthcare events, there is none more important than the JPMorgan Healthcare Conference. Filled with dozens upon dozens of biotech and medical device companies, the JPMorgan Healthcare...
JPM: 58.83 (-0.51), ICPT: 146.18 (-3.82), GSK: 42.93 (+0.13), FOLD: 8.88 (+0.04), CELG: 117.00 (+3.33)
24.9% Return Seen to Date on SmarTrend Amicus Therapeutics Call (FOLD)
Comtex SmarTrend(R) - Wed Dec 31, 5:00PM CST
SmarTrend identified an Uptrend for Amicus Therapeutics (NASDAQ:FOLD) on November 17th, 2014 at $6.66. In approximately 1 month, Amicus Therapeutics has returned 24.92% as of today's recent price of $8.32.
FOLD: 8.88 (+0.04)
Use Options For A Chance To Buy FOLD At A 33% Discount
at The Street - Wed Dec 31, 10:47AM CST
Looking back to 43 days ago, Amicus Therapeutics Inc priced a 13,850,000 share secondary stock offering at $6.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the...
FOLD: 8.88 (+0.04)
Shares of FOLD Up 20.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Dec 24, 11:12AM CST
SmarTrend identified an Uptrend for Amicus Therapeutics (NASDAQ:FOLD) on November 17th, 2014 at $6.66. In approximately 1 month, Amicus Therapeutics has returned 20.57% as of today's recent price of $8.03.
FOLD: 8.88 (+0.04)
Amicus: Multiple Catalysts For Promising Fabry Treatment
Value Insight - at Seeking Alpha - Wed Dec 24, 11:01AM CST
FOLD: 8.88 (+0.04)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 4:35PM CST
AG: 6.78 (+0.54), CAMP: 17.36 (-0.08), AU: 10.77 (+0.63), UWTI: 2.95 (-0.51), ONTX: 4.23 (-0.14), NQ: 4.38 (-0.07), TPLM: 4.53 (-0.02), EPE: 8.78 (-0.40), GSAT: 2.72 (+0.03), FOLD: 8.88 (+0.04)
Amicus Therapeutics Added to NASDAQ Biotechnology Index (NBI)
GlobeNewswire - Mon Dec 22, 6:38AM CST
Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced that the Company was added to the NASDAQ Biotechnology Index (Nasdaq:NBI) (Nasdaq:XNBI), effective prior to the market open on December 22, 2014.
FOLD: 8.88 (+0.04)
Amicus Therapeutics to Present Program Updates at 33rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Mon Dec 22, 6:30AM CST
New Cardiac Data from Migalastat Monotherapy Phase 3 Study 011 for Fabry Disease
JPM: 58.83 (-0.51), FOLD: 8.88 (+0.04)
Shares of FOLD Up 16.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Dec 17, 9:51AM CST
SmarTrend identified an Uptrend for Amicus Therapeutics (NASDAQ:FOLD) on November 17th, 2014 at $6.66. In approximately 1 month, Amicus Therapeutics has returned 16.07% as of today's recent price of $7.73.
FOLD: 8.88 (+0.04)
Nasdaq makes annual changes to Biotechnology Index
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 11:36AM CST
TTPH: 39.27 (-3.99), ZSPH: 40.88 (-0.14), AMRN: 1.06 (-0.02), OPHT: 51.28 (+0.35), AERI: 29.51 (-0.58), ASPX: 59.91 (+0.57), CNCE: 13.53 (-0.20), ICEL: 5.52 (-0.15), GWPH: 78.73 (+0.20), AUXL: 36.44 (-0.07), RTRX: 13.52 (-0.09), RCPT: 120.88 (-3.63), AAVL: 58.85 (+0.19), AKBA: 11.43 (-0.07), EXPR: 14.57 (+0.45), RARE: 55.81 (+1.75), RLYP: 33.57 (+0.84), PETX: 18.67 (+0.07), ENTA: 49.41 (-0.70), RDUS: 38.90 (-2.02), CARA: 10.99 (+0.04), FLML: 18.23 (-0.03), ALIM: 5.66 (-0.07), ANIP: 55.88 (-0.07), ICPT: 146.18 (-3.82), RVNC: 17.05 (-0.10), POZN: 6.94 (-0.85), FPRX: 28.00 (+3.09), ZFGN: 37.55 (-2.01), CRIS: 1.40 (-0.01), QLTI: 4.49 (+0.10), PCYC: 123.71 (-0.49), PTX: 8.82 (+0.03), CLDN: 18.35 (-0.25), RIGL: 2.15 (-0.04), HPTX: 25.22 (+0.27), AMPH: 12.00 (+0.02), INO: 9.30 (-0.19), VSAR: 22.93 (-0.28), FMI: 46.74 (+22.81), TBPH: 16.84 (-0.58), XLRN: 40.89 (-0.25), MGNX: 33.87 (-0.04), INSM: 14.60 (-0.95), ONTX: 4.23 (-0.14), ALDR: 29.05 (+0.98), SAGE: 43.81 (-0.58), KITE: 82.35 (+3.21), CGEN: 9.26 (-0.03), FOLD: 8.88 (+0.04), KPTI: 29.90 (-2.14)
Annual Changes to the NASDAQ Biotechnology Index
GlobeNewswire - Mon Dec 15, 6:10AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 22, 2014.
TTPH: 39.27 (-3.99), ZSPH: 40.88 (-0.14), AMRN: 1.06 (-0.02), OPHT: 51.28 (+0.35), AERI: 29.51 (-0.58), ASPX: 59.91 (+0.57), CNCE: 13.53 (-0.20), ICEL: 5.52 (-0.15), GWPH: 78.73 (+0.20), AUXL: 36.44 (-0.07), RTRX: 13.52 (-0.09), RCPT: 120.88 (-3.63), AAVL: 58.85 (+0.19), AKBA: 11.43 (-0.07), EXPR: 14.57 (+0.45), RARE: 55.81 (+1.75), ZGNX: 1.38 (-0.07), RLYP: 33.57 (+0.84), PETX: 18.67 (+0.07), ENTA: 49.41 (-0.70), RDUS: 38.90 (-2.02), CARA: 10.99 (+0.04), FLML: 18.23 (-0.03), ALIM: 5.66 (-0.07), ANIP: 55.88 (-0.07), ICPT: 146.18 (-3.82), RVNC: 17.05 (-0.10), POZN: 6.94 (-0.85), NDAQ: 47.35 (-1.15), FPRX: 28.00 (+3.09), CRIS: 1.40 (-0.01), ZFGN: 37.55 (-2.01), QLTI: 4.49 (+0.10), PCYC: 123.71 (-0.49), PTX: 8.82 (+0.03), CLDN: 18.35 (-0.25), RIGL: 2.15 (-0.04), HPTX: 25.22 (+0.27), AMPH: 12.00 (+0.02), INO: 9.30 (-0.19), VSAR: 22.93 (-0.28), FMI: 46.74 (+22.81), TBPH: 16.84 (-0.58), XLRN: 40.89 (-0.25), MGNX: 33.87 (-0.04), INSM: 14.60 (-0.95), ONTX: 4.23 (-0.14), ALDR: 29.05 (+0.98), SAGE: 43.81 (-0.58), KITE: 82.35 (+3.21), CGEN: 9.26 (-0.03), FOLD: 8.88 (+0.04), KPTI: 29.90 (-2.14)
Amicus provides 2015 outlook
Seeking Alpha - at Seeking Alpha - 2 hrs 38 mins ago
FOLD: 8.88 (+0.04)
Amicus Therapeutics Provides Full-Year 2015 Strategic Outlook and Financial Guidance
GlobeNewswire - Mon Jan 12, 6:30AM CST
MAA Submission for Migalastat Monotherapy for Fabry Disease on Track for Mid-2015
FOLD: 8.88 (+0.04)
Amicus Therapeutics (FOLD) Weak On High Volume
at The Street - Fri Jan 09, 9:03AM CST
Trade-Ideas LLC identified Amicus Therapeutics (FOLD) as a weak on high relative volume candidate
FOLD: 8.88 (+0.04)
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1
at The Street - Thu Jan 08, 12:09PM CST
The much ballyhooed J.P. Morgan Healthcare Conference kicks off Monday in San Francisco. Here are capsule summaries of some of the expected story lines from presenting companies.
OREX: 5.75 (-0.03), BIIB: 347.84 (+5.50), VRTX: 118.31 (-3.90), ESRX: 83.08 (-1.82), ACAD: 34.25 (+0.88), PCYC: 123.71 (-0.49), GILD: 101.21 (-1.00), NPSP: 45.35 (+3.44), SNY: 44.92 (+0.37), FOLD: 8.88 (+0.04), CELG: 117.00 (+3.33)
Migalstat HCL has positive impact on cardiac endpoint in Fabry study
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 10:31AM CST
FOLD: 8.88 (+0.04)
41.4% Return Seen to Date on SmarTrend Amicus Therapeutics Call (FOLD)
Comtex SmarTrend(R) - Thu Jan 08, 9:09AM CST
SmarTrend identified an Uptrend for Amicus Therapeutics (NASDAQ:FOLD) on November 17th, 2014 at $6.66. In approximately 2 months, Amicus Therapeutics has returned 41.44% as of today's recent price of $9.42.
FOLD: 8.88 (+0.04)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 8:15AM CST
NRX: 7.90 (-1.19), BIND: 6.76 (-0.45), NBG: 1.66 (+0.09), MBT: 7.95 (-0.16), STML: 16.33 (+0.52), BIOD: 1.55 (-0.03), SIG: 124.42 (-0.50), PBR: 6.57 (-0.49), NBIX: 29.51 (+1.22), PIR: 16.75 (-0.01), VLCCF: 5.08 (+0.49), CONN: 18.28 (+0.22), CYTR: 3.44 (-0.14), PLX: 2.34 (+0.05), MEET: 1.43 (+0.01), INFI: 15.15 (+0.38), CYRN: 2.09 (+0.07), APOL: 26.05 (-0.89), CJJD: 3.16 (+0.39), CRK: 5.15 (-0.51), FOLD: 8.88 (+0.04), GST: 2.21 (-0.17)
Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac Endpoints From Fabry Monotherapy Study 011 and Long Term Extension Study
GlobeNewswire - Thu Jan 08, 6:41AM CST
Statistically Significant Improvements in Key Cardiac Parameter in Fabry Patients Previously Naïve to Therapy
FOLD: 8.88 (+0.04)
Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains
at The Street - Tue Jan 06, 7:25PM CST
The markets are presenting a buying opportunity at current levels, but only if you know which stocks to buy, Cramer says.
TSLA: 202.21 (-4.45), GE: 23.98 (-0.05), OVAS: 49.24 (-0.92), NMM: 12.41 (+0.12), XOM: 90.33 (-1.77), T: 33.49 (+0.09), ESPR: 48.52 (+3.58), IBM: 156.44 (-2.67), IRE: 14.01 (-0.12), DTV: 84.72 (-0.66), PTCT: 53.70 (+0.08), RCPT: 120.88 (-3.63), TEG: 77.50 (-0.53), PPG: 226.25 (-0.72), WAG: 76.05 (-0.49), BLUE: 101.95 (-1.68), TGTX: 15.98 (-0.88), WFC: 52.05 (-0.63), BA: 130.87 (-0.67), RAD: 7.79 (-0.04), ISIS: 73.34 (+1.08), RNA: 18.77 (+0.01), ACHN: 14.64 (+0.08), JCP: 8.14 (+0.23), CVS: 97.20 (-0.72), MCD: 93.01 (-0.20), AGIO: 131.55 (+3.43), CVX: 105.88 (-2.33), VZ: 47.08 (+0.32), FOLD: 8.88 (+0.04)
3 Biotech Stocks We're Watching Closest Ahead of the JPMorgan Healthcare Conference
Motley Fool Staff - Motley Fool - Mon Jan 05, 6:52AM CST
Source: GlaxoSmithKline via Flickr. When it comes to healthcare events, there is none more important than the JPMorgan Healthcare Conference. Filled with dozens upon dozens of biotech and medical device companies, the JPMorgan Healthcare...
JPM: 58.83 (-0.51), ICPT: 146.18 (-3.82), GSK: 42.93 (+0.13), FOLD: 8.88 (+0.04), CELG: 117.00 (+3.33)
24.9% Return Seen to Date on SmarTrend Amicus Therapeutics Call (FOLD)
Comtex SmarTrend(R) - Wed Dec 31, 5:00PM CST
SmarTrend identified an Uptrend for Amicus Therapeutics (NASDAQ:FOLD) on November 17th, 2014 at $6.66. In approximately 1 month, Amicus Therapeutics has returned 24.92% as of today's recent price of $8.32.
FOLD: 8.88 (+0.04)
Use Options For A Chance To Buy FOLD At A 33% Discount
at The Street - Wed Dec 31, 10:47AM CST
Looking back to 43 days ago, Amicus Therapeutics Inc priced a 13,850,000 share secondary stock offering at $6.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the...
FOLD: 8.88 (+0.04)
Shares of FOLD Up 20.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Dec 24, 11:12AM CST
SmarTrend identified an Uptrend for Amicus Therapeutics (NASDAQ:FOLD) on November 17th, 2014 at $6.66. In approximately 1 month, Amicus Therapeutics has returned 20.57% as of today's recent price of $8.03.
FOLD: 8.88 (+0.04)
Amicus: Multiple Catalysts For Promising Fabry Treatment
Value Insight - at Seeking Alpha - Wed Dec 24, 11:01AM CST
FOLD: 8.88 (+0.04)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 4:35PM CST
AG: 6.78 (+0.54), CAMP: 17.36 (-0.08), AU: 10.77 (+0.63), UWTI: 2.95 (-0.51), ONTX: 4.23 (-0.14), NQ: 4.38 (-0.07), TPLM: 4.53 (-0.02), EPE: 8.78 (-0.40), GSAT: 2.72 (+0.03), FOLD: 8.88 (+0.04)
Amicus Therapeutics Added to NASDAQ Biotechnology Index (NBI)
GlobeNewswire - Mon Dec 22, 6:38AM CST
Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced that the Company was added to the NASDAQ Biotechnology Index (Nasdaq:NBI) (Nasdaq:XNBI), effective prior to the market open on December 22, 2014.
FOLD: 8.88 (+0.04)
Amicus Therapeutics to Present Program Updates at 33rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Mon Dec 22, 6:30AM CST
New Cardiac Data from Migalastat Monotherapy Phase 3 Study 011 for Fabry Disease
JPM: 58.83 (-0.51), FOLD: 8.88 (+0.04)
Shares of FOLD Up 16.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Dec 17, 9:51AM CST
SmarTrend identified an Uptrend for Amicus Therapeutics (NASDAQ:FOLD) on November 17th, 2014 at $6.66. In approximately 1 month, Amicus Therapeutics has returned 16.07% as of today's recent price of $7.73.
FOLD: 8.88 (+0.04)
Nasdaq makes annual changes to Biotechnology Index
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 11:36AM CST
TTPH: 39.27 (-3.99), ZSPH: 40.88 (-0.14), AMRN: 1.06 (-0.02), OPHT: 51.28 (+0.35), AERI: 29.51 (-0.58), ASPX: 59.91 (+0.57), CNCE: 13.53 (-0.20), ICEL: 5.52 (-0.15), GWPH: 78.73 (+0.20), AUXL: 36.44 (-0.07), RTRX: 13.52 (-0.09), RCPT: 120.88 (-3.63), AAVL: 58.85 (+0.19), AKBA: 11.43 (-0.07), EXPR: 14.57 (+0.45), RARE: 55.81 (+1.75), RLYP: 33.57 (+0.84), PETX: 18.67 (+0.07), ENTA: 49.41 (-0.70), RDUS: 38.90 (-2.02), CARA: 10.99 (+0.04), FLML: 18.23 (-0.03), ALIM: 5.66 (-0.07), ANIP: 55.88 (-0.07), ICPT: 146.18 (-3.82), RVNC: 17.05 (-0.10), POZN: 6.94 (-0.85), FPRX: 28.00 (+3.09), ZFGN: 37.55 (-2.01), CRIS: 1.40 (-0.01), QLTI: 4.49 (+0.10), PCYC: 123.71 (-0.49), PTX: 8.82 (+0.03), CLDN: 18.35 (-0.25), RIGL: 2.15 (-0.04), HPTX: 25.22 (+0.27), AMPH: 12.00 (+0.02), INO: 9.30 (-0.19), VSAR: 22.93 (-0.28), FMI: 46.74 (+22.81), TBPH: 16.84 (-0.58), XLRN: 40.89 (-0.25), MGNX: 33.87 (-0.04), INSM: 14.60 (-0.95), ONTX: 4.23 (-0.14), ALDR: 29.05 (+0.98), SAGE: 43.81 (-0.58), KITE: 82.35 (+3.21), CGEN: 9.26 (-0.03), FOLD: 8.88 (+0.04), KPTI: 29.90 (-2.14)
Annual Changes to the NASDAQ Biotechnology Index
GlobeNewswire - Mon Dec 15, 6:10AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 22, 2014.
TTPH: 39.27 (-3.99), ZSPH: 40.88 (-0.14), AMRN: 1.06 (-0.02), OPHT: 51.28 (+0.35), AERI: 29.51 (-0.58), ASPX: 59.91 (+0.57), CNCE: 13.53 (-0.20), ICEL: 5.52 (-0.15), GWPH: 78.73 (+0.20), AUXL: 36.44 (-0.07), RTRX: 13.52 (-0.09), RCPT: 120.88 (-3.63), AAVL: 58.85 (+0.19), AKBA: 11.43 (-0.07), EXPR: 14.57 (+0.45), RARE: 55.81 (+1.75), ZGNX: 1.38 (-0.07), RLYP: 33.57 (+0.84), PETX: 18.67 (+0.07), ENTA: 49.41 (-0.70), RDUS: 38.90 (-2.02), CARA: 10.99 (+0.04), FLML: 18.23 (-0.03), ALIM: 5.66 (-0.07), ANIP: 55.88 (-0.07), ICPT: 146.18 (-3.82), RVNC: 17.05 (-0.10), POZN: 6.94 (-0.85), NDAQ: 47.35 (-1.15), FPRX: 28.00 (+3.09), CRIS: 1.40 (-0.01), ZFGN: 37.55 (-2.01), QLTI: 4.49 (+0.10), PCYC: 123.71 (-0.49), PTX: 8.82 (+0.03), CLDN: 18.35 (-0.25), RIGL: 2.15 (-0.04), HPTX: 25.22 (+0.27), AMPH: 12.00 (+0.02), INO: 9.30 (-0.19), VSAR: 22.93 (-0.28), FMI: 46.74 (+22.81), TBPH: 16.84 (-0.58), XLRN: 40.89 (-0.25), MGNX: 33.87 (-0.04), INSM: 14.60 (-0.95), ONTX: 4.23 (-0.14), ALDR: 29.05 (+0.98), SAGE: 43.81 (-0.58), KITE: 82.35 (+3.21), CGEN: 9.26 (-0.03), FOLD: 8.88 (+0.04), KPTI: 29.90 (-2.14)
